Kingston, MA – June 16, 2011 –
Microway’s GPU Computing Solutions with NVIDIA Tesla GPUs were awarded the prestigious Best New Technology award at the Life Sciences Technology Insight Summit in Boston yesterday. A uniquely comprehensive educational and executive summit, the event featured a multitude of case study presentations and interactive panels from executives from leading life sciences organizations and industry associations.
Attendees interacting with Microway representatives saw a stunning 3D display of DNA pulled through a synthetic nanopore, driven by NAMD software running on Microway’s WhisperStation-PSC (personal supercomputer). The WhisperStation included two NVIDIA Tesla C2070 GPUs and Quadro 6000 graphics using NVIDIA’s 3D Vision Pro technology.
Two of Microway’s customers presented case studies on their research and implementation of Microway Tesla GPU-based computational platforms in drug discovery and cancer treatment.
Dr. Preston Moore, of University of the Sciences in Philadelphia, demonstrated how Microway WhisperStations and clusters with Tesla GPUs enabled accelerated understanding of the physicochemical properties of biological membranes. Dr. Moore’s research is leading to new drug discovery and increased understanding of membrane interaction.
Dr. John Wolfgang of Massachusetts General Hospital presented a case study success on “SHADIE: A Quantitative, GPU-based Volume Rendering Solution for Radiation Oncology.” Running on Microway WhisperStation-Tesla PSC and remote NVIDIA Tesla S-Series GPU servers, MGH is now able to treat cancer patients using live radiotherapy visualization. They can also provide immediate estimates of patient radiation exposure under the conditions of any specified shader. Both applications would have been impossible to implement with only CPU-based computational power.
“Computational biochemistry enables researchers to quickly sort through large databases of biomolecules and drug candidates,” said Sumit Gupta, Tesla product line manager at NVIDIA. “Microway’s award-winning WhisperStation-LS uses the performance of NVIDIA Tesla GPUs to accelerate these bioscience applications to rapidly advance scientific research.”
Microway’s Tesla solutions for life sciences are delivered fully integrated with CUDA SDK and Linux or Windows. In April, Microway’s BioStack-LS cluster was awarded Best of Show at the Bio-IT World Conference in Boston. WhisperStations and BioStack-LS clusters offer advanced manageability features that have been refined over years of development and thousands of real-world cluster deployments.
“Molecular dynamics, quantum chemistry, visualization/rendering, and bioinformatics applications are particularly well suited for massive parallelism. With speedups exceeding 10x on many applications, scientists can leverage Tesla GPUs to achieve smaller footprints with increased computational power. Microway’s Tesla-based WhisperStation and computational clusters are the ideal foundation for this accelerated research,” commented Stephen Fried, Microway’s President and CTO.
A complete product description can be found at: http://www.microway.com/tesla/
About Microway, Inc.
Incorporated in 1982, Microway is a major vendor in the High Performance Computing market, designing state-of-the-art, high-end Linux clusters, servers, and data storage solutions. Users worldwide pushing the limits of technology choose us for solutions. These include universities, life sciences, financial, military, Fortune 500s, and research agencies. Microway is an Intel Channel Premier provider and Tesla Preferred Partner. Classified as a small business, woman owned and operated, Microway’s GSA Contract Number is GS-35F-0431N. For more information and a subscription to Microway’s online technical newsletter, please visit www.microway.com.
About Life Sciences Technology Insight Summit
Life Sciences Technology Insight Summit showcases the latest industry research, market trends and product solutions surrounding the life sciences industry. The summit is laser-focused on the business issues and the bottom-line impact of technology on pharmaceutical, biotechnology or medical device organizations.
Over one and a half business-intensive days, a pre-qualified audience of IT and business executives from North America’s pharmaceutical marketplace joins together to:
- Hear the latest research and content from Life Science Industry expert
- Participate in case study/ qualitative presentations that demonstrate the successful, real-world implementation of IT solutions for life sciences applications and environments
- Build critical collaborative relationships with peers, thought leaders and current and future vendor partners
This event is managed by CrossTech Forums, which produces hosted executive-level summits that enable top corporate decision-makers, vendors, associations and thought leaders to share knowledge and build partnerships in today’s global marketplace.
About NVIDIA
NVIDIA is the world leader in visual computing technologies and the inventor of the GPU, a high-performance processor which generates breathtaking, interactive graphics on workstations, personal computers, game consoles, and mobile devices. NVIDIA serves the entertainment and consumer market with its GeForce® graphics products, the professional design and visualization market with its Quadro® graphics products and the high-performance computing market with its Tesla™ computing solutions products. NVIDIA is headquartered in Santa Clara, Calif. and has offices throughout Asia, Europe, and the Americas. For more information, visit www.nvidia.com.
Microway, BioStack, InfiniScope, FasTree, Quadputer, and WhisperStation are trademarks or registered trademarks of Microway, Inc.
Intel and Nehalem are trademarks of Intel corporation. Microsoft and Windows are registered trademarks of Microsoft Corporation in the U.S. and/or other jurisdictions.
